AMGN

Amgen Inc. News Headlines

$144.01
*  
1.99
1.4%
Get AMGN Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Amgen Q2 14 Earnings Conference Call At 5:00 PM ET
7/29/2014 3:00:00 PM - RTT News

After-Hours Earnings Report for July 29, 2014 : AXP, AMGN, APC, ESRX, AFL, EQR, AMP, VRTX, MAR, BXP, FISV, NEM
7/29/2014 2:00:02 PM - NASDAQ.com News

Will Amgen (AMGN) Disappoint This Earnings Season? - Analyst Blog
7/28/2014 5:15:00 PM - Zacks.com

Kinder Morgan Energy Partners, Travelers And Amgen Top 'Best Value' Long-Term Bond Rankings
7/28/2014 3:37:00 PM - Seeking Alpha

Daily Dividend Report: K, WWE, AMGN, ETR, AVY, RBC
7/28/2014 3:24:05 PM - BNK Invest

Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog
7/25/2014 2:45:00 PM - Zacks.com

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
7/25/2014 10:52:00 AM - Seeking Alpha

Bayer and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed
7/25/2014 3:21:00 AM - Dow Jones Business News

Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
7/25/2014 2:44:00 AM - RTT News

FDA Accepts Sandoz Application For Biosimilar Filgrastim - Quick Facts
7/24/2014 1:26:00 AM - RTT News

IPO Preview: Atara Biotherapeutics
7/24/2014 1:21:00 AM - Seeking Alpha

Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog
7/23/2014 2:15:00 PM - Zacks.com

Amgen Can Propel Over $120 With Earnings Right Around The Corner
7/22/2014 2:22:00 PM - Seeking Alpha

Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 4:07:46 PM - Zacks.com

Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog
7/21/2014 1:23:00 PM - Zacks.com

Notable ETF Inflow Detected - IWB, AMGN, UNH, BMY
7/21/2014 11:12:38 AM - BNK Invest

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

Anthera Acquires Sollpura from Eli Lilly - Analyst Blog
7/18/2014 5:20:00 PM - Zacks.com

Amgen: Grappling With The Reality Of Patent Expiries
7/18/2014 7:26:00 AM - Seeking Alpha

Amgen Reports Positive Phase 3 Results For Thyroid Drug AMG 416
7/17/2014 7:20:00 PM - RTT News

Celladon Lock-Up Expiration Could Be A Short Opportunity For Aggressive Investors
7/16/2014 5:32:00 PM - Seeking Alpha

Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog
7/16/2014 3:03:00 PM - Zacks.com

Q2 2014 Update: My Whistler Income And Growth Portfolio
7/15/2014 2:24:00 PM - Seeking Alpha

Yellen Swats Down Biotech, Social Stocks
7/15/2014 12:57:00 PM - Fox Business

Cytokinetics Up on Positive Tirasemtiv Data - Analyst Blog
7/14/2014 5:00:00 PM - Zacks.com